CASH FLOWS FROM OPERATING ACTIVITIES | |
Net income (loss) | 137.23M |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |
Depreciation and amortization | 47.49M |
Impairment of goodwill and other intangibles | |
Unrealized loss on available for sale investment | |
Deferred income taxes | -9.38M |
Tax benefit from stock based compensation | |
Equity in net (income) loss of equity-method investees | 108K |
Stock based compensation | 10.01M |
Contingent consideration expense | |
Interest accretion on contingent consideration | |
Other non-cash items, net | 7.4M |
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions: | |
Accounts receivable | -29.2M |
Inventories | -11.4M |
Other current assets | -650K |
Other assets | 1.11M |
Accounts payable and accrued expenses | -13.73M |
Acquisition-related contingent consideration | |
Income taxes | |
Net cash provided by operating activities | 131.85M |
CASH FLOWS FROM INVESTING ACTIVITIES | |
Acquisitions, net of cash acquired | -157.86M |
Purchases of property and equipment | -58.02M |
Proceeds from disposals of property and equipment | |
(Advances to) repayments from equity-method investees, net | |
Deconsolidation of subsidiary | |
Net cash provided by (used in) investing activities | -215.89M |
CASH FLOWS FROM FINANCING ACTIVITIES | |
Proceeds (payments) from bank revolving credit facility, net | 63.85M |
Repayments of other long-term debt, net | |
Acquisition-related contingent consideration | 0 |
Shares withheld for payment of employee payroll taxes | -25.16M |
Investments by and advances from minority shareholder in joint venture | |
Proceeds from exercise of stock options, net of related expenses | 0 |
Excess tax benefits from share-based compensation | 11.31M |
Net cash provided by (used in) financing activities | 47.62M |
Effect of exchange rate changes on cash | -5.12M |
Net increase (decrease) in cash and cash equivalents | -41.53M |
Cash and cash equivalents at beginning of year | 166.92M |
Cash and cash equivalents at end of year | 125.39M |